bpc-157 human clinical trials 2024 2025 If worked as well as the internet says it does… …we'd probably have high quality by now. Instead we have... Lots of rat studies. Lots of podcasts. Lots of BPC-157 and Blood Pressure: Effects

A March 2026 community synthesis noted a divided user base: some reporting consistent benefit, others reporting none

The COA included endotoxin and sterility data which our lab requires

MSCs could reduce the production of inflammatory factors such as IL, TGF, TNF and interferon (IFN), inhibit the proliferation of T and B cells, reduce IgG secretion, inhibit the maturation of dendritic cell and regulate the activities of other immune cells such as natural killer cells and macrophages (214)

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance

Research Use Disclaimer: This article is intended for educational and scientific purposes only